✉news BusinessRetail first seen 1 d ago, last 1 d ago, peak #33
Analyst Cuts Capricor Therapeutics Price Target By 86%
Original: This Analyst Slashed CAPR Stock’s Target By 86% – But, Retail Bulls Say Setup Offers An Attractive Risk-Reward
An analyst slashed the price target on Capricor Therapeutics (CAPR) stock by 86%, a dramatic downgrade for the biotech. Retail investors, however, are pushing back, arguing the current share price still offers an attractive risk-reward setup despite the sharply reduced target. The split between Wall Street caution and retail bullishness is driving debate over the stock's near-term prospects.
Why now: The size of the price target cut and the clash with bullish retail sentiment is drawing attention to the stock.
Evidence
- This Analyst Slashed CAPR Stock’s Target By 86% – But, Retail Bulls Say Setup Offers An Attractive Risk-Reward · Stocktwits
API: https://socialmediatrends-api.osmike.com/v1/trends/978941